Seattle Children's Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Seattle Children's Hospital brings 2 presentations to ASH 2026 in New Orleans. Its program centres on acute lymphoblastic leukemia across all ages, including next steps for children now that chemo-immunotherapy is used from the start. It also offers a practical approach to immune transfusion reactions in sickle cell disease.
| Organization | ASH 2026 Attendance |
|---|---|
Seattle Children's Hospital Seattle, WA | |
Pediatric hospital and research institute in Seattle, Washington. | Talk Immune-Mediated Transfusion Reactions in Sickle Cell Disease: A Practical Approach Telling apart hyperhemolysis and delayed hemolytic transfusion reactions in sickle cell disease, and why it matters for prognosis, future transfusions and treatment. Talk Next Steps for Treatment of Pediatric ALL in the Era of Frontline Chemo-Immunotherapy Whether adding inotuzumab or CAR-T to frontline treatment of childhood B-cell acute lymphoblastic leukemia can safely reduce chemotherapy and its toxicity. Session The Golden Era of ALL Management: Rapid Advances Across the Age Spectrum How blinatumomab, CAR-T cells and other immunotherapies are reshaping acute lymphoblastic leukemia care and reducing chemotherapy across all ages. Talk |
Instantly find 20 buyers from Seattle Children's Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction